Latest Content

CVS Pharmacy acquires stores and prescription files from over 600 Rite Aid and Bartell Drugs pharmacies.

Experts discussed safe and effective management strategies for patients with hidradenitis suppurativa at the 2025 Skin of Color Update.

Arthritis care remains fragmented and costly, with access disparities prompting calls for preventive strategies, community resources, and systemic improvements.

The number of Black, Hispanic, and Latino students admitted into medical schools fell as rates increased for White and Asian students.

Research highlights the need for diverse data on drug efficacy in atopic dermatitis to address barriers to treatment for patients with skin of color, notes Elain Siegfried, MD.

Eliot F. Battle, MD, discusses how to effectively and successfully treat skin of color.

The new indication allows doctors to use upadacitinib before tumor necrosis factor–blocking agents when those treatments are clinically inadvisable.

Opioids were more likely to be prescribed to Medicare beneficiaries living with HIV, which led to opioid use disorder (OUD).

Infliximab biosimilars created price competition causing insurance claims costs for infliximab originator and infliximab biosimilars to decrease, generating significant savings to the health care system.